FIGURE

Figure 4

ID
ZDB-FIG-221214-131
Publication
Poudel et al., 2022 - Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation
Other Figures
All Figure Page
Back to All Figure Page
Figure 4

Involvement of FoxM1 on osteoclast differentiation and oxidative stress. RAW 264.7 cells were cultured for 4 days with M-CSF (30 ng/mL) and RANKL (50 ng/mL) and treated with resveratrol (RES), MitoTEMPO (MT) and doxorubicin (DOX) alone or together. RNA from the cells was obtained, and expression levels for FoxM1 (A), Sod 1 (B) and Nrf 2 (C) were analyzed by qPCR. One-way ANOVA, Tukey’s multiple comparisons test, *—p ≤ 0.05, **—p ≤ 0.01, ***—p ≤ 0.001, ****—p ≤ 0.0001.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.